Search
Ionis Pharmaceuticals Inc
IONSAdd to Watchlist
74.120USD
-0.190-0.26%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
12.10BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mar 4, 2025
Currency: USDUpdated: Mar 4, 2025
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
R&D revenue under collaborative agreements
364.56M
49.99%
SPINRAZA royalties
286.58M
39.30%
Product sales, net
70.00M
9.60%
Licensing and other Royalty revenue
8.12M
1.11%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
R&D revenue under collaborative agreements
364.56M
49.99%
SPINRAZA royalties
286.58M
39.30%
Product sales, net
70.00M
9.60%
Licensing and other Royalty revenue
8.12M
1.11%
